Incyte Corporation (INCY)
NASDAQ: INCY · Real-Time Price · USD
101.13
+2.57 (2.61%)
May 11, 2026, 10:11 AM EDT - Market open

Incyte Revenue

Incyte had revenue of $1.27B in the quarter ending March 31, 2026, with 20.87% growth. This brings the company's revenue in the last twelve months to $5.36B, up 21.48% year-over-year. In the year 2025, Incyte had annual revenue of $5.14B with 21.22% growth.

Revenue (ttm)
$5.36B
Revenue Growth
+21.48%
P/S Ratio
3.67
Revenue / Employee
$1,885,028
Employees
2,844
Market Cap
20.20B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20255.14B900.02M21.22%
Dec 31, 20244.24B545.57M14.76%
Dec 31, 20233.70B301.01M8.87%
Dec 31, 20223.39B408.37M13.67%
Dec 31, 20212.99B319.57M11.98%
Dec 31, 20202.67B507.94M23.53%
Dec 31, 20192.16B276.88M14.71%
Dec 31, 20181.88B345.66M22.50%
Dec 31, 20171.54B430.50M38.93%
Dec 31, 20161.11B351.97M46.70%
Dec 31, 2015753.75M242.26M47.36%
Dec 31, 2014511.50M508.45M16,696.71%
Dec 31, 20133.05M-294.01M-98.97%
Dec 31, 2012297.06M202.60M214.50%
Dec 31, 201194.46M-75.42M-44.40%
Dec 31, 2010169.88M160.61M1,733.55%
Dec 31, 20099.27M5.35M136.41%
Dec 31, 20083.92M-30.52M-88.62%
Dec 31, 200734.44M6.80M24.59%
Dec 31, 200627.64M19.80M252.32%
Dec 31, 20057.85M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Jazz Pharmaceuticals4.44B
Genmab3.90B
BioNTech SE3.23B
Royalty Pharma2.44B
Moderna2.23B
Ascendis Pharma998.25M
Insmed819.56M
BridgeBio Pharma579.96M
Revenue Rankings